Topical Anti-TNF[alpha] Agent Licaminlimab
Topical Anti-TNF[alpha] Agent Licaminlimab
About this item
Full title
Topical Anti-TNF[alpha] Agent Licaminlimab
Author / Creator
Publisher
Dove Medical Press Limited
Journal title
Clinical ophthalmology (Auckland, N.Z.), 2022-07, Vol.16, p.2167
Language
English
Formats
Publication information
Publisher
Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Purpose: To assess the efficacy, safety, and pharmacokinetics of new topical ocular anti-TNF[alpha] antibody fragment licaminlimab in the relief of persistent ocular discomfort in severe dry eye disease (DED). Patients and Methods: Patients with [greater than or equal to] 6-month history of DED, regular use of artificial tears, and best-corrected v...
Alternative Titles
Full title
Topical Anti-TNF[alpha] Agent Licaminlimab
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_healthsolutions_A714421151
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_healthsolutions_A714421151
Other Identifiers
ISSN
1177-5483
How to access this item
Log in as a Library member
